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ABSTRACT

A novel computational method and generation of mutant

butyrylcholinesterase for cocaine hydrolysis is provided. The
method includes molecular modeling a possible BChE
mutant and conducting molecular dynamics simulations and
hybrid quantum mechanical/molecular mechanical calcula
tions thereby providing a screening method of possible BChE
mutants by predicting Which mutant Will lead to a more stable
transition state for a rate determining step. Site-directed

mutagenesis, protein expression, and protein activity is con
ducted for mutants determined computationally as being
good candidates for possible BChE mutants, i.e., ones pre

dicted to have higher catalytic e?iciency as compared With
Wild-type BChE. In addition, mutants A199S/A328W/

Zhan, et al., Fundamental reaction mechanism for cocaine metabo
lism in human butyrylcholinesterase, J. Am., Chem. Soc. 2003, 125,

Y332G, A199S/F227A/A328W/Y332G, A199S/S287G/

2462-2474.

A328W/Y332G,

HamZa, et al., Molecular dynamics simulation of cocaine binding
With human butyrylcholinesterase and its mutants, J. Phys. Chem. B
2005, 109, 4776-4782.
Zhan, et al., Catalytic mechanism and energy barriers for

and

A199S/F227A/S287G/A328W/Y332G,

A199S/F227A/S287G/A328W/E441D

butyrylcholinesterase-catalyzed hydrolysis of cocaine, D. Biophysi
cal Journal 2005, 89, 3863-3872.

all

have

enhanced catalytic ef?ciency for (—)-cocaine compared With
Wild-type BChE.
4 Claims, 6 Drawing Sheets
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HIGH-ACTIVITY MUTANTS OF
BUTYRYLCHOLINESTERASE FOR
COCAINE HYDROLYSIS AND METHOD OF
GENERATING THE SAME

-continued
H3C

\N+/H

FIELD OF THE INVENTION
O

The present invention relates to butyrylcholinesterase vari

\

ant polypeptides, and in particular, butyrylcholinesterase

OCH3

BChE
4»

mutants having amino acid substitutions.

H2O

—>

O

/

O=C

BACKGROUND OF THE INVENTION

Cocaine abuse is a major medical and public health prob

(+)—cocaine

lem that continues to defy treatment. The disastrous medical
and social consequences of cocaine addiction, such as violent

crime, loss in individual productivity, illness and death, have
made the development of an effective pharmacological treat
ment a high priority. HoWever, cocaine mediates its reinforc

20

ing and toxic effects by blocking neurotransmitter reuptake
and the classical pharmacodynamic approach has failed to
yield small-molecule receptor antagonists due to the di?icul
ties inherent in blocking a blocker. An alternative to receptor

H3C

based approaches is to interfere With the delivery of cocaine
to its receptors and accelerate its metabolism in the body.
The dominant pathWay for cocaine metabolism in primates

is butyrylcholinesterase (BChE)-catalyZed hydrolysis at the
benZoyl ester group (Scheme 1).

\

N+ , H

25

O§C /OH
O

30

+

ocH3
OH

35

40

Scheme 1. Schematic representation of BChE-catalyzed
hydrolysis at the benZoyl ester group.
Only 5% of the cocaine is deactivated through oxidation by
the liver microsomal cytochrome P450 system. Cocaine

hydrolysis at benZoyl ester group yields ecgonine methyl
45

ester, Whereas the oxidation produces norcocaine. The
metabolite ecgonine methyl ester is a biologically inactive
metabolite, Whereas the metabolite norcocaine is hepatotoxic
and a local anesthetic. BChE is synthesiZed in the liver and

Widely distributed in the body, including plasma, brain, and
50

55

lung. Extensive experimental studies in animals and humans
demonstrate that enhancement of BChE activity by adminis
tration of exogenous enZyme substantially decreases cocaine
half-life.
Enhancement of cocaine metabolism by administration of
BChE has been recogniZed to be a promising pharmacoki

netic approach for treatment of cocaine abuse and depen

dence. HoWever, the catalytic activity of this plasma enZyme
is three orders-of-magnitude loWer against the naturally
occurring (—)-cocaine than that against the biologically inac
tive (+)-cocaine enantiomer. (+)-cocaine can be cleared from
plasma in seconds and prior to partitioning into the central
nervous system (CNS), Whereas (—)-cocaine has a plasma

half-life of approximately 45-90 minutes, long enough for
manifestation of the CNS effects Which peak in minutes.
65

Hence, BChE mutants With high activity against (—)-cocaine
are highly desired for use in humans. Although some BChE

mutants With increased catalytic activity over Wild-type

US 7,438,904 B1
3

4

BChE have previously been generated, there exists a need for

of BChE. As expected, the structure of BChE is similar to a

mutant BChE With even higher catalytic activity. Thus, prior
mutants provide limited enhancement in catalytic activity

previously published theoretical model of this enZyme and to
the structure of acetylcholinesterase.
The main difference betWeen the experimentally deter

over Wild-type BChE.

Previous studies such as (a) Masson, P.; Legrand, P.; Bar

mined BChE structure and its model Was found at the acyl

tels, C. F.; Froment, M-T.; Schopfer, L. M.; Lockridge, 0.
Biochemistry 1997, 36, 2266 (b) Masson, P.; Xie, W., Fro
ment, M-T.; Levitsky, V.; Fortier, P.-L.; Albaret, C.; Lock
ridge, O. Biochim. Biophys. Acla 1999, 1433, 281, (c) Xie,
W.; Altamirano, C. V.; Bartels, C. F.; Speirs, R. J.; Cashman,
J. R.; Lockridge, 0. Mol. Pharmacol. 1999, 55, 83, (d) Duy

binding pocket (acyl loop) that is signi?cantly bigger than
expected. It is unclear Whether the structural difference at the

acyl binding pocket signi?cantly affect BChE binding With
(—)-cocaine and (+)-cocaine. Although previous MD simula
tions of cocaine binding With Wild-type BChE and the reac
tion coordinate calculations point to some amino acid resi
dues that might need to be mutated for the purpose of

sen, E. G.; Bartels, C. F.; Lockridge, O. J. Pharmacol. Exp.

Ther. 2002, 302, 751, (e) Nachon, F.; Nicolet,Y.; V1guie, N.;

improving the catalytic activity for (—)-cocaine hydrolysis, it

Masson, P.; Fontecilla-Camps, J. C.; Lockridge, 0. Eur. J.
Biochem. 2002, 269, 630, (f) Zhan, C.-G.; Landry, D. W. J.
Phys. Chem. A 2001, 105, 1296; Berkman, C. E.; Underiner,
G. E.; Cashman, J. R. Biochem. Pharmcol. 1997, 54, 1261;

(g) Sun, H.; YaZal, J. E.; Lockridge, O.; Schopfer, L. M.;
Brimijoin, S.; Pang,Y.-P. J. Biol. Chem. 2001, 276, 9330, (h)
Sun, H.; Shen, M. L.; Pang,Y. P.; Lockridge, O.; Brimijoin, S.
J. Pharmacol. Exp. Then 2002, 302, 710, Sun, H.; Pang,Y.
P.; Lockridge, O.; Brimijoin, S. Mol. Pharmacol. 2002, 62,
220 (hereinafter “Sun et al”); and (j) Zhan, C.-G.; Zheng, F.;

remained unknoWn Which exact amino acid mutations Will

result in a BChE With a higher catalytic activity for (—)
cocaine.
Computational studies of Wild-type BChE and cocaine
from Sun, et al, based on a “homology model,” suggest that
20

cocaine is the rotation of the cocaine in the active site of

Landry, D. W. J Am. Chem. Soc. 2003, 125, 2462 (hereinafter

“Zhan et al”), herein all incorporated by reference, suggested
that, for both (—)-cocaine and (+)-cocaine, the BChE-sub
strate binding involves tWo different types of complexes:

25

“to provide a cation-p interaction to restore substrate a?inity
lost in disabling the p-p interaction.”
30

using human plasma and in vivo studies Were conducted

studied using molecular modeling. The three dimensional
35

softWare. Cocaine Was docked to the catalytic gorge of the

horizontally at the bottom of the gorge. The main structural
40

corresponding BChE-(+)-cocaine complexes exists in the
relative position of the cocaine methyl ester group. Reaction
coordinate calculations revealed that the rate-determining
45

change from the non-prereactive complex to the prereactive
active complex reveals speci?c amino acidresidues hindering
50

(—)-cocaine.
Previous molecular dynamics (MD) simulations of prere
active BChE-cocaine binding Were limited to Wild-type
55

performed on any prereactive enZyme-substrate complex for
60

287G/A328W and A119S/F227A/S287G/A328W/Y332M.

homology model of BChE When three-dimensional (3D)
X-ray crystal structure Was not available for BChE, as taught

J. C.; Nachon, F. J Biol. Chem. 2003, 278, 41141 (hereinafter
“Nicolet et al”), recently reported 3D X-ray crystal structures

cocaine hydrolysis activity. For example, mutants include
F227A/A328W; F227A/S287G/A328W; A119S/S287G/
A328W; A328W/Y332M/S287G/F227A, A199S/F227A/S/
The mutants have varying increases in catalytic activity, up to
100-fold increase relative to Wild-type BChE.

of BChE interacting With cocaine Were performed based on a

by Nicolet,Y.; Lockridge, O.; Masson, P.; Fontecilla-Camps,

complicated catalytic reaction process. As it is Well-knoWn, it
is particularly challenging to model and simulate the detailed
reaction pathWay and predict the kinetics of such an enZy
matic reaction.
U.S. Patent Application Publication Nos. 2004/0121970;
2004/0120939; and 2003/0153062, describe 20+BChE
mutants, or “variants,” from human and other animals, each
having from one to six amino acid alterations and increased

caine Was reported by Sun et al. No MD simulation Was

(—)- or (+)-cocaine binding With a mutant BChE. In addition,
all previous computational studies of Sun et al and Zhan et al

It should be noted that all prior computational techniques

(molecular docking and molecular dynamics simulation)
used by other researchers are based on an empirical force ?eld
Which cannot be used to perform any necessary reaction
coordinate calculation for the detailed understanding of the

complex is rate determining. A further analysis of the struc
tural changes from the non-prereactive complex to the prere

BChE. Even for the non-prereactive BChE-cocaine complex,
only one mutant (A328W/Y332A) BChE binding With (—)
cocaine Was simulated and its catalytic activity for (—)-co

mutant BChE using other commercially available softWare.
The cocaine-enZyme complex Was re?ned by molecular
dynamic simulation. The data generated by the molecular
modeling studies Were consistent With enZyme assays and
kinetic data.

step of BChE-catalyzed hydrolysis of (+)-cocaine is the

the structural changes, providing initial clues for the rational
design of BChE mutants With improved catalytic activity for

(3D) structure of A328W/Y332A Was generated from the

computationally generated 3D model of Wild-type BChE and
changing the relevant residues using commercially available

distance for nucleophilic attack and hydrolysis by S198 (pre
reactive complex). In the prereactive complex, cocaine lies

chemical reaction process, Whereas for (—)-cocaine the

Sun et al studied the A328W/Y332A BChE mutant using
enZyme assays and kinetics. In vitro studies Were conducted
using male Sprague-DaWley rats. The mutant Was found to
have enhanced catalytic properties. The mutant Was further

then rotates to a position in the catalytic site Within a favorable

difference betWeen the BChE-(—)-cocaine complexes and the

BChE. By decreasing the hindrance of the rotation, the rate of
the hydrolysis may be enhanced. Sun, et al describes creating
an A328W/Y332A BChE mutant by: (1) replacing Tyr332
With Ala, “to reduce the steric hindrance and the p-p interac

tion that impede rotation,” and (2) replacing Ala328 With Trp

non-prereactive and prereactive BChE-substrate complexes.
Whereas the non-prereactive BChE-cocaine complexes Were
?rst reported by Sun et al, Zhan et al Were the ?rst reporting
the prereactive BChE-cocaine complexes and reaction coor
dinate calculations, disclosed in Zhan et al. It Was demon
strated that (—)/(+)-cocaine ?rst slides doWn the substrate
binding gorge to bind to W82 and stands vertically in the
gorge betWeen D70 and W82 (non-prereactive complex) and

the rate-determining step for BChE-catalyzed hydrolysis of

There exists a need in the art for determining Which pro
65

posed mutant BChEs should have ever increasing catalytic
activity and for generating those mutants Which should have

enhanced catalytic activity.

US 7,438,904 B1
5
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SUMMARY OF THE INVENTION

cocaine hydrolysis by performing molecular modeling and

The present invention includes ?ve novel human BChE

MD simulations on the transition state structures of possible
mutants of BChE. This method is an improvement over tra

mutants that have unexpected increased catalytic e?iciency
for cocaine hydrolysis. The mutants have various unique
amino acid residue substitutions Which provide the surprising

ditional random-search approaches, Which, given the com
plex catalytic mechanism of cocaine hydrolysis, makes it
dif?cult to improve the catalytic activity of BChE for cocaine

enhanced catalytic activity. These mutants are (1) A199S/
A328W/Y332G mutant (SEQ ID NO: 2), Which has a

hydrolysis.

approximately 65-fold improved catalytic e?iciency against
(—)-cocaine; (2) A199S/F227A/A328W/Y332G mutant

linesterase variant peptide comprising an amino acid
sequence selected from the group consisting of SEQ ID NOS:

(SEQ ID NO: 8), Which has an approximately 148-fold

2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30.

The present invention in one form, concerns a butyrylcho

improved catalytic ef?ciency against (—)-cocaine; (3) A1 99S/

The present invention in another form thereof concerns a

S287G/A328W/Y332G mutant (SEQ ID NO: 14), Which has

nucleic acid molecule comprising a nucleic acid sequence
Which encodes a butyrylcholinesterase variant peptide, the
nucleic acid sequence selected from the group consisting of

an approximately 456-fold improved catalytic e?iciency

against (—)-cocaine; (4) A199S/F227A/S287G/A328W/
Y332G mutant (SEQ ID NO: 20), Which has an approxi

SEQ ID NOS: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27,

mately 1,003-fold improved catalytic e?iciency against (—)

and 29.
The present invention in another form thereof concerns a

cocaine; and (5) A199S/F227A/S287G/A328W/E441D

pharmaceutical composition comprising a butyrylcholinest

mutant (SEQ ID NO: 26), Which has an approximately 445

fold improved catalytic e?iciency against (—)-cocaine.

20

catalytic activity of the enzyme. SEQ ID NOS: 4, 10, 16, 22

erase variant polypeptide comprising an amino acid sequence

selected from the group consisting of SEQ ID NOS. 2, 4, 6, 8,
10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30; and a suitable

In addition, the aforementioned mutant amino acid
sequences can be truncated Without substantially affecting
the catalytic activity so that amino acid residues 1-67 and
443-574 can be removed Without substantially affecting the

pharmaceutical carrier.
The present invention in another form thereof concerns a
25

method for treating a cocaine-induced condition comprising

and 28 are the amino acid sequences for residue 68-142

administering to an individual an effective amount of butyryl

corresponding to mutants 1-5, respectively. In addition, With

cholinesterase variant peptide having an amino acid sequence

regard to mutants 1-4, it Was found that amino acid residues
before 117 and after 438 could be removed Without substan

selected from the group consisting of SEQ ID NOS. 2, 4, 6, 8,
10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30, to loWer blood

tially changing the activity of the mutant enZymes, resulting
in truncated amino acid sequences having SEQ ID NOS: 6,
12, 18 and 24, respectively. Finally With regard to mutant 5,

30

cocaine concentration.
The present invention is another form thereof concerns a

method for treating a cocaine induced condition comprising

amino acid residues before 117 and after 441 could be

administering to an individual an effective amount of a phar

removed Without substantially changing its activity resulting

maceutical composition comprising a butyrylcholinesterase

in SEQ ID NO: 30.
These aforementioned truncated sequences all of With
similar catalytic activity is based on protein structures.
Further, the present invention is directed to a novel and

unique pharmaceutical composition Which comprises a
butyrylcholinesterase variant, namely mutants 1-5, along

35

group consisting ofSEQ ID NOS. 2, 4, 6, 8, 10, 12, 14, 16, 18,
20, 22, 24, 26, 28, and 30, and suitable pharmaceutical carrier
of claim 3 to an individual in an effective amount to loWer
40

With a suitable pharmaceutical carrier. The pharmaceutical
composition can be administered to an individual in an effec

tive amount to loWer the patient’s cocaine blood concentra

blood cocaine concentration.
The present invention in yet another form thereof concerns
a method for generating butyrylcholinesterase mutants. The
method includes generating an initial structure of the transi
tion state structure for the rate-determining step of the

cocaine hydrolysis catalyZed by a possible butyrylcholinest

tion and in particular (—)-cocaine blood concentration.
In addition, the present invention is directed to a novel and

variant having an amino acid sequence selected from the

45

unique method for developing mutants Which have enhanced
catalytic ef?ciency. The generation method includes both a

erase mutant. A suf?ciently long time molecular dynamics
simulation is performed on the transition state structure in
Water to have a stable molecular dynamics trajectory. The

computational portion and an experimental portion. With

molecular dynamics trajectory is analyZed and the hydrogen

regard to the computational portion, a variety of state of the

bonding energies are estimated betWeen the carboxyl oxygen
of the (—)-cocaine benZyl ester and the oxyanion hole of the
possible butyrylcholinesterase mutant. If the overall hydro
gen binding energy betWeen the carboxyl oxygen of the (—)
cocaine benZyl ester and the possible butyrylcholinesterase
mutant, in the transition state, is stronger than the overall
hydrogen binding energy betWeen the carboxyl oxygen of the

art computational techniques including molecular modeling,
molecular dynamics (MD) simulations and hybrid quantum
mechanical/molecular mechanical (QM/MM) calculations,

50

provide a virtual screening of possible BChE mutants. This
virtual screening predicts Which mutation Will lead to a more
stable transition state for a rate-determining step compared to

55

(—)-cocaine benZyl ester and the Wild-type butyrylcholinest
erase, optionally, hybrid quantum mechanical/molecular
mechanical (QM/MM) geometry optimiZation is performed

the corresponding separated reactants, i.e., free cocaine and
free enZyme. The more stable the transition state, the loWer

the energy barrier, and the higher the catalytic ef?ciency.
FolloWing the computational portion, an experimental test is
portion. The experimental test includes site-directed

to re?ne the molecular dynamics-simulated structure, the
hydrogen binding energies are calculated and the energy bar
rier is evaluated. Finally, the butyrylcholinesterase mutant is

mutagenesis, protein expression, and enZyme activity assay.

generated.

then conducted on the possible mutants of the computation

60

In various alternative embodiments, the generating an ini

The experimental tests are conducted on mutants Which are

predicted to have a high catalytic ef?ciency against (—)-co
caine than the Wild-type BChE and/or other knoWn BChE

mutants against (—)-cocaine. Thus, the present method iden
ti?es or predicts mutants having high catalytic activity for

tial structure of the transition state structure is based on reac
65

tion coordinate calculations for the Wild-type butyrylcho
linesterase. The generating butyrylcholinesterase mutant
includes performing site-directed mutagenesis on a nucleic

US 7,438,904 B1
7
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acid sequence Which includes Wild-type butyrylcholinest

tioned residues hinders the (+)-cocaine rotation in the BChE
active site from the non-prereactive complex to the prereac
tive complex in accordance With the present invention.
FIG. 4A depicts the (—)-cocaine rotation in the active site of

erase to generate the mutant butyrylcholinesterase nucleic

acid sequence. Using the mutant butyrylcholinesterase
nucleic acid sequence, the protein encoded by the mutant
nucleic acid sequences is expressed to produce mutant

A328W/Y332A; FIG. 4B depicts the (—)-cocaine rotation in

butyrylcholinesterase and catalytic activity assay is per

the active site of A328W/Y332G BChE from the non-preac

formed on the mutant butyrylcholinesterase.

tive complex to the prereactive complex; and FIG. 4C depicts
the (—)-cocaine rotation in the active site of Wild-type BChE.
FIG. 5A is a plot of the key internuclear distances (in A)

The hybrid quantum mechanical/molecular mechanical

geometry optimiZation may include calculating the hydrogen
binding energies and evaluating the energy barriers only if the
overall hydrogen binding energy betWeen the carboxyl oxy
gen of the (—)-cocaine benZyl ester and the possible butyryl

versus the time in the simulated TSl structure for (—)-cocaine

hydrolysis catalyZed by A328W/Y332A; and FIG. 5B for
A199S/A328W/Y332G BChE.
FIG. 6 is a plot of key internuclear distances (in A) versus
the time in the simulated TSl structure for (—)-cocaine

cholinesterase mutant, in the transition state, is stronger than

knoWn butyrylcholinesterase mutants against (—)-cocaine.

hydrolysis catalyZed by A199S/S287G/A328W/Y332G

In yet another alternative further embodiment, the method
for generating butyrylcholinesterase mutants further includes

BChE.

determining the rate-limiting step in the hydrolysis of (—)
DETAILED DESCRIPTION OF THE PREFERRED
EMBODIMENTS

cocaine by the possible butyrylcholinesterase mutant by con
ducting molecular dynamics simulations and quantum
mechanical/molecular mechanical calculations relating to the
transition states for other reaction steps betWeen (—)-cocaine

20

by the possible butyrylcholinesterase mutant and calculating
respective energy barriers, thereby establishing Which of the
reaction steps is the rate-determining one.
25

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 are plots of distances in the MD simulation (—)
cocaine binding With A328W/Y332G BChE versus the simu

The present invention has tWo major improvements over
the prior art. The ?rst is the presently discovered BChE
mutants, mutant 1, A199S/A328W/Y332G; mutant 2,
A199S/F227A/A328W/Y332G; mutant 3, A199S/S287G/
A328W/Y332G; mutant 4, A199S/F227A/S287G/A328W/
Y332G; and mutant 5, A199S/F227A/S287G/A328W/E441
D each have a signi?cantly higher catalytic ef?ciency. The
second improvement is concerning the mutant designing or

discovering process.

lation time, along With root-mean-square deviation (RMSD)
in the enzyme-substrate complexes Where FIG. 1A represents
the non-prereactive enzyme-substrate complexes; and FIG.
1B represents the prereactive enzyme-substrate complexes in
accordance With the present invention.
FIG. 2 shoWs the binding of structures of the simulated

The BChE mutants 1-5 have full length amino acid

30

sequences, SEQ ID NOS: 2, 8, 14, 20, and 26, respectively,
Which are encoded by nucleic acid sequences having SEQ ID
NOS: 1, 7, 13, 19, and 25, respectively. Table 1 summarizes
the catalytic ef?ciency against (—)-cocaine for the ?ve
35 mutants.

non-prereactive and prereactive complexes of Wild-type

In addition to the full length BChE mutants, the respective

BChE binding With tWo entomers of cocaine in Which FIG.

amino acid sequence can be truncated Without substantially

2A depicts BChE (—)-cocaine non-prereactive complex; FIG.
2B depicts BChE (—)-cocaine prereactive complex, FIG. 2C
depictes BChE (+)-cocaine non-prereactive complex; and
FIG. 2D depicts BChE (+)-cocaine prereactive complex.

affecting the respective catalytic activity. With all mutants,
residues 1-67 and 443-574 can be removed Without substan
40

BChE. Further, With regard to mutant 1-4, amino acids 1-1 16
and 439-574 canbe omitted Without substantially affecting its

FIG. 3A shoWs the (—)-cocaine rotation in the BChE active
site for the non-prereactive complex to the prereactive com

plex hindered by some residues at positions Y332, A328, and
F329 residues in the non-prereactive complexes Which are
signi?cantly different from the corresponding positions in the
prereactive complex; and FIG. 3B shoWs the (+)-cocaine

tially affecting the catalytic activity of the respective mutant
respective catalytic activity. With regard to mutant 5, amino
acid residues 1-116 and 442-574 can be omitted Without

45

rotation in the BChE active site Where none of the aforemen

substantially affecting its catalytic activity. Table 1 also pro
vides a summary of amino acid SEQ ID NOS and correspond
ing nucleic acid SEQ ID NOS for the aforementioned trun
cated mutant BChE sequences.

TABLE 1
Partially Truncated

Mutant Amino Acid
Number Substituting
1
2
3

4

A199S/A328W/
Y332G
A199S/F227N
A3 28W/Y 3 32G
A199S/S287G/
A3 28W/Y 3 32G
A199S/F227N
S287G/A328W/

Nucleic Acid Amino Acid
SEQ ID NO. SEQ ID NO.

Nucleic Acid

SEQ ID NO

Sequence

Corresponding

SEQ ID NO.

Catalytic

Corresponding

SEQ ID NO.

To Amino Acid

for Amino

Ef?ciency

To Amino Acid
Residues 68-442

for Amino Acid
Residues 68-442

Residues
117-43 8/441 *

Acid Residues
117-438/441*

Against
(—)-cocaine

1

2

3

4

5

6

65-fold

7

8

9

10

11

12

148-fold

13

14

15

16

17

18

456-fold

19

20

21

22

22

24

1,003-fold

US 7,438,904 B1
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TABLE l-continued
Partially Truncated

Mutant Amino Acid
Number Substituting
5

A199S/F227N
S287G/A328W/
E441 D

Nucleic Acid Amino Acid
SEQ ID NO. SEQ ID NO.
25

26

Nucleic Acid

SEQ ID NO

Sequence

Corresponding

SEQ ID NO.

Catalytic

Corresponding

SEQ ID NO.

To Amino Acid

for Amino

Ef?ciency

To Amino Acid
Residues 68-442

for Amino Acid
Residues 68-442

Residues
117-43 8/441*

Acid Residues
117-43 8/441*

Against
(—)-cocaine

27

28

29

30

445-fold

(*Amino acid residues 117-438 for mutants 1-4 and residues 117-441 for mutant 5.)

The BChE variant polypeptide, e. g., SEQ ID NOS: 2, 4, 6, 15 tory. The molecular dynamics trajectory is analyzed and the
hydrogen binding energies are estimated betWeen the car
8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30 can be
formulated in a pharmaceutical composition along With a
boxyl oxygen of the (—)-cocaine benzoyl ester and the oxya
suitable pharmaceutical carrier knoWn to one skilled in the
art.

The present BChE variant polypeptides can be used in
treating a cocaine-induced condition by administering to an

20

individual, an effective amount of one of the BChE variant

zoyl ester and the Wild-type BChE, hybrid quantum mechani
cal/molecular mechanical (QM/MM) geometry optimization

polypeptides, i.e., SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14, 16, 18,
20, 22, 24, 26, 28, and 30, to loWer blood cocaine concentra
tion. The BChE variant polypeptide may be administered in
the form of a pharmaceutical composition in Which the BChE
variant is included With a suitable pharmaceutical carrier.
Treatment of a cocaine induced condition using one of the
aforementioned BChE variant polypeptides can be done in
accordance With Zhan et al., page 2463.
The preferred dose for administration of a butyrylcho

nion hole of the possible BChE mutant. If the overall hydro
gen binding energy betWeen the carboxyl oxygen of the (—)
cocaine benzoyl ester and the possible BChE mutant, in the
transition state, is stronger than the overall hydrogen binding
energy betWeen the carboxyl oxygen of the (—)-cocaine ben

25

30

is performed to re?ne the molecular dynamics-simulated
structure, the hydrogen binding energies are calculated and
the energy barrier is evaluated. The QM/MM calculations
make the computational predictions more reliable. Finally,
the BChE mutant is generated.
With regard to the molecular dynamics (MD) simulations
and quantum mechanical/molecular mechanical (QM/MM)

linesterase or peptide composition in accordance With the

calculations, the ?rst chemical reaction step of (—)-cocaine

present invention is that amount Which Will be effective in

hydrolysis catalyzed by butyrylcholinesterase (BChE)
mutants and, When needed, other reaction steps are modeled

lowering (—)-cocaine concentration in a patient’s blood
stream, and one Would readily recognize that this amount Will
vary greatly depending on the nature of cocaine consumed,
e.g., injected or inhaled, and the condition of a patient. An
“effective amount” of butyrylcholinesterase mutant or phar
maceutical agent to be used in accordance With the invention

35

BChE’ s are created using site-directed mutagenesis folloWed

by protein expression. The aforementioned ?ve mutants Were

identi?ed by computational analysis and generated by site

is intended to mean a nontoxic but su?icient amount of the 40

agent, such that the desired prophylactic or therapeutic effect
is produced. Thus, the exact amount of the enzyme or a

particular agent that is required Will vary from subject to
subject, depending on the species, age, and general condition
of the subject, the severity of the condition being treated, the
particular carrier or adjuvant being used and its mode of

45

should also be adjusted to suit the individual to Whom the
composition is administered and Will once again vary With

stable transition state leads to a loWer energy barrier and

higher predicted catalytic el?ciency. Only after the computa
tional analysis predicts enhanced catalytic ef?ciency, is site
55

mutant BChE protein is then used in catalytic as says to deter

mine the catalytic ef?ciency against (—)-cocaine.
60

The use of predictive, computational modeling of the
present method for identifying mutant BChE candidates and
the resulting mutant BChE are novel and unexpected over

prior conventional methods Which Will noW be readily appar

rate-determining step for the cocaine hydrolysis catalyzed by
structure in Water to have a stable molecular dynamics traj ec

directed mutagenesis conducted on Wild-type BChE nucleic
acid sequence to generate a mutant nucleic acid sequence
Which is then used to express a mutant BChE protein. The

ating an initial structure of the transition state structure for the

a possible BChE mutant. A suf?ciently long time molecular
dynamics simulation is performed on the transition state

step compared to the corresponding separated reagents, i.e.,
free cocaine and free possible mutant BChE, Where the more

A unique method Was used to determine potential BChE

mutants With projected increased catalytic activity for the
hydrolysis of cocaine. The method provides a unique
approach Which ?rst models the potential BChE mutant inter
action With cocaine folloWed by generating the BChE mutant
if the predicted model indicates that the BChE variant should
have enhanced catalytic activity. The method includes gener

of molecular modeling of a potential BChE mutant and MD
simulations and QM/MM calculations provide virtual screen

lead to a more stable transition state for the rate determining
50

erase composition Will vary based on the particular circum
stances, and an appropriate effective amount may be deter
mined in each case of application by one of ordinary skill in

the art using only routine experimentation.

directed mutagenesis Which have signi?cantly enhanced (—)
cocaine hydrolysis catalytic ef?ciency compared With Wild
type BChE.
In the present method computational analysis in the form
ing of possible BChE mutants Which have predicted enhanced
catalytic activity for (—)-cocaine. For example, the MD simu
lations and QM/MM calculations predict Which mutation Will

administration, and the like. Similarly, the dosing regimen
age, Weight, metabolism, etc. of the individual. Accordingly,
the “effective amount” of any particular butyrylcholinest

and calculated using molecular dynamics simulations and
QM/MM calculations. Following this modeling, mutant

ent to one of ordinary skill in the art.
65

Using the present method, most discovered neW mutants
include a speci?c mutation (Y332G) on residue #332. No
prior BChE mutant having the Y332G mutation had ever been

US 7,438,904 B1
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reported previously; only mutations Y332A and Y332M on
residue #332 had been tested previously by other researchers.
that a mutant includingY332G mutation should be better than
the corresponding mutant including Y332A mutation or
Y332M. Thus, the present mutants With a Y332G mutation

The present method includes molecular dynamics simula
tions performed on the cocaine binding With both the Wild
type BChE and the mutants Whereas prior molecular dynam
ics simulations Were only performed on the cocaine binding
With the Wild-type BChE. As is shoWn beloW in the folloWing
experiments, the computational prediction could be com

Which have enhanced catalytic activity represent a surprising

pletely Wrong Without directly modeling and simulating

and unexpected result over prior BChE mutants.
A Y332G mutant (single mutation) Was ?rst tested and
found that the Y332G mutant had a slightly loW (or approxi

cocaine binding With the proposed mutants.

Prior to the present invention, there Was no reason to expect

The present invention Will noW be discussed With regard to

the folloWing non-limiting examples in the form of experi
ments Which are provided to enhance understanding of the
present invention but in no Way limit its scope or applicability.

mately equal) catalytic ef?ciency than the Wild-type. So, only
an appropriate combination of different mutations on differ
ent residues could make the enZyme more active. As seen

Experiment 1

beloW, the prior art did not reveal that any of the particular
combinations tested Was expected to have an improved cata

Computational Study of Cocaine Binding With

lytic ef?ciency. The present method is based on the present

Wild-Type and Mutant BChE’s for A328W/Y332G,
A328W/Y332A, and A328W/Y332A/Y419S

unique, extensive computational modeling and simulations of
the detailed catalytic mechanism for both the Wild-type BChE
and the mutants.

The primary improvement of the present method over the

20

prior art is that high-performance computational modeling
and simulations of the detailed catalytic mechanism are per

formed, Which includes modeling hoW cocaine binds With
BChE and the subsequent structural transformation and
chemical reaction process. The prior art only considered the
cocaine binding With the enZyme (BChE) and Was unable to
examine the detailed catalytic reaction process after the
BChE-cocaine binding. When molecular modeling Was lim
ited to studying the BChE-cocaine binding, one could only
design a mutation to improve the BChE-cocaine binding

A detailed computational study of cocaine binding With
Wild-type and mutant BChE’s starting from the available
X-ray crystal structure of Wild-type BChE Was performed.
The simulated mutants include A328W/Y332G, A328W/

Y332A, and A328W/Y332A/Y419S, as simple geometric
25

consideration of the binding site suggests that these mutations
could be important for changing the (—)-cocaine rotation from

the non-prereactive complex to the prereactive complex. Wet

Without knowing Whether the mutation Will also speedup the

experimental tests Were conducted on the catalytic activity of
these mutants for (—)-cocaine in order to verify the computa
tional predictions. All of the obtained results clearly demon
strate that molecular modeling and MD simulations of
cocaine binding With BChE mutants provide a reliable com

subsequent chemical reaction process or not.

putational approach to the rational design of high-activity

To overcome the obstacles of prior challenges to using
computational techniques such as molecular docking and

30

mutants of BChE for the (—)-cocaine hydrolysis.

molecular dynamics simulation previously used by others

3D model of BChE. The initial coordinates of human
BChE used in the computational studies came from the X-ray

Which Were based on an empirical force ?eld Which cannot be

crystal structure deposited in the Protein Data Bank (pdb

used to perform necessary reaction coordinate calculations
for the catalytic reaction process, a variety of state-of-the-art

code: 1 POP). The missing residues (D2, D3, E255, D378,
D379, N455, L530, E531, and M532) in the X-ray crystal

computational techniques of homology modeling, molecular
docking, molecular dynamics, quantum mechanics (QM),

35

and hybrid quantum mechanics/molecular mechanics (QM/

structure Were built using the automated homology modeling
tool Modeler disclosed by Sali, A.; Blundell, T. L. J. Mol.
Biol. 1990, 212 403, and Sali, A.; Blundell, T. L. J. Mol. Biol.

MM) Were used for the rational design of the BChE mutants.
The combined use of these computational techniques, includ

lnsightll softWare (Accelrys, Inc.) with the default param

ing QM and QM/MM, led to the study of the detailed reaction
coordinate of the BChE-catalyzed hydrolysis of cocaine
Which, for the ?rst time, provided the detailed structures of all

40

1993, 234, 779, herein incorporated by reference, and
45 eters.

Molecular docking. Molecular docking Was performed for

each non-prereactive protein-ligand binding complex. The

transition states and intermediates existing in the reaction

process and the corresponding energetics. These extensive
computational modeling and simulation studies provided for
the rational design of possible BChE mutants that not only

binding site Was de?ned as a sphere With an approximately 15
50

can improve the BChE-cocaine binding, but also can speedup

A radius around the active site residue S198. The amino acid
residues included in the binding site model are not contiguous
in the protein. Cocaine, considered as a ligand, Was initially
positioned at 17 A in front of S198 of the binding site. Each

the subsequent chemical reaction process. As a result, one can

BChE-cocaine binding complex Was energy-minimized by

noW quickly discover the BChE mutants With the signi?

using the steepest descent algorithm ?rst until the maximum

cantly improved catalytic ef?ciency.

55

from the prior modeling. The molecular modeling in the prior
art considered only one binding mode for each BChE-cocaine

system, Without modeling the possible cocaine rotation in the

60

BChE active site after the binding. The present method con
siders tWo different binding modes for each BChE-cocaine
system and the structural transformation betWeen them: non

prereactive and prereactive BChE-cocaine complexes. The
present modeling provides more detailed information about
the BChE-cocaine binding and the subsequent structural
transformation.

energy derivative is smaller than 4 kcal/mol/A and then the

conjugated gradient algorithm until the maximum energy

In addition, to the differences mentioned above, the present
molecular modeling of the BChE-cocaine binding also differs

65

derivative is smaller than 0.001 kcal/mol/A. The energy mini
miZation Was folloWed by a 300 ps molecular dynamics (MD)
simulation at T:298 K With a time step of 1 fs. During the
energy minimiZation and MD simulation, only cocaine and
the residues of BChE included in the binding site Were
alloWed to move, While the remaining part of the protein Was
?xed. The energy-minimization and MD simulation for these
processes Were performed by using the Amber force ?eld

implemented in the Discoveri3/lnsightll calculation engine,
disclosed by Cornell, W. D.; Cieplak, P.; Bayly, C. 1.; Gould,
l. R.; MerZ, Jr., K. M.; Ferguson, D. M.; Spellmeyer, D. C.;

US 7,438,904 B1
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Fox, T.; Caldwell, 1. W.; Kollman, P. A. J. Am. Chem. Soc.
1995, 117, 5179. The non-bonded cut-off method and the

During the 500 ps production MD simulation, the coordinates

dielectric constant Were set up to group based (12 A cut-off

Molecular docking and MD simulation procedures
described above Were performed to study cocaine binding
With Wild-type BChE and three mutants, i.e., A328W/
Y332A, A328W/Y332A/Y419S, and A328W/Y332G. For
each protein system (Wild-type or mutant BChE), the protein

of the simulated complex Were saved every 1 ps.

distance) and distance dependent, respectively (e:4r) in
accordance With Harvey, S. C. Proteins 1989, 5, 78-92, herein

incorporated by reference.
Molecular dynamic simulation in Water. The initial coor

dinates used in the MD simulation of the non-prereactive

binding With cocaine Was considered in both the non-prere

complexes Were determined by using the molecular docking
procedure described above, Whereas the initial coordinates

active and prereactive enzyme-substrate complexes.

used in the MD simulation of the prereactive complexes Were

supercomputer, Superdome (shared-memory, With 4 nodes

obtained from superimposing backbone of the X-ray crystal

and 256 processors), at the Center for Computational Sci
ences, University of Kentucky. The other computations Were

Most of the MD simulations in Water Were performed on a

structure to that of the previously disclosed simulated prere
active complex of Zhan et al betWeen cocaine and a homology
model of Wild-type BChE. Each BChE-cocaine binding com

carried out on SGI Fuel Workstations and a 34-processors

IBM x335 Linux cluster.

Experimental procedure. Site-directed mutagenesis of

plex Was neutralized by adding tWo chloride counterions and

human BChE cDNA Was performed by the QuikChange
method of Braman, 1.; PapWorth, C.; Greener, A. Methods

Was solvated in a rectangular box of TIP3P Water molecules

With a minimum solute-Wall distance of 10 A. The general
procedure for carrying out the MD simulations in Water is
similar to that used in our previously reported other compu
tational studies such as those in Zhan et al and (a) Zhan, C.-G.;

20

Mutations Were generated from Wild-type human BChE in a

pRc/CMV expression plasmid in accordance With Xie, W.;
Altamirano, C. V.; Bartels, C. F.; Speirs, R. 1.; Cashman, 1. R.;
Lockridge, 0. Mol. Pharmacol. 1999, 55, 83, all herein incor

Norberto de Souza, O.; Riftenhouse, R.; Ornstein, R. L. J. Am.

Chem. Soc. 1999, 121, 7279, (b) Koca, 1.; Zhan, C.-G.; Rit

25

817, (c) Koca, 1.; Zhan, C.-G.; Rittenhouse, R. C.; Ornstein,

Pearlman, D. A.; Caldwell, 1. W.; Cheatham III, T. E.; Wang,
1.; Ross, W. S.; Simmerling, C. L.; Darden, T.A.; Merz, K. M.;
Stanton, R. V.; Cheng, A. L.; Vincent, 1. 1.; CroWley, M.; Tsui,
V.; Gohlke, H.; Radmer, R. 1.; Duan,Y.; Pitera, 1.; Massova, I.;
Seibel, G. L.; Singh, U. C.; Weiner, P. K.; Kollman, P. A.
(2002), AMBER 7, University of California, San Francisco,

mutations Were made by polymerase chain reaction With Pfu

DNA polymerase, for replication ?delity. The PCR product
30

ligand Was frozen and the solvent molecules With counterions

Was treated With Dpn I endonuclease to digest the parental
DNA template. Modi?ed plasmid DNA Was transformed into

Escherichia coli, ampli?ed, and puri?ed. The DNA
sequences of the mutants Were con?rmed by DNA sequenc

ing. BChE mutants Were expressed in human embryonic kid
35

ney cell line 293T/ 17. Cells Were groWn to 80-90% con?u

ence in 6-Well dishes and then transfected by Lipofectamine
2000 complexes of 4 pg plasmid DNA per each Well. Cells

herein incorporated by reference. The solvated system Was

optimized prior to the MD simulation. First, the protein

porated by reference, kindly provided by Dr. Lockridge at
University of Nebraska Medical Center. Using plasmid DNA
as template and primers With speci?c base-pair alterations,

tenhouse, R.; Ornstein, R. L. J. Am. Chem. Soc. 2001, 123,

R. L.J Compul. Chem. 2003, 24, 368, herein all incorporated
by reference. These simulations Were performed by using the
Sander module of Amber7 program as taught by Case, D. A.;

Mol. Biol. 1996, 57, 5731, herein incorporated by reference.

40

Were incubated at 370 C. in a C02 incubator for 24 hours and
cells Were moved to 60-mm culture vessel and cultured for
four more days. The culture medium [10% fetal bovine serum

in Dulbecco’s modi?ed Eagle’s medium (DMEM)] Was har

Were alloWed to move during a 5000-step minimization With

vested for a BChE activity assay. To measure cocaine and

the conjugate gradient algorithm and a 5 ps MD run at T:300
K. After full relaxation and the entire solvated system Was

benzoic acid, the product of cocaine hydrolysis by BChE, We

energy-minimized, the system Was sloWly heated from T:10

45

dance With Masson, P.; Xie, W., Froment, M-T.; Levitsky, V.;
Fortier, P.-L.; Albaret, C.; Lockridge, 0. Biochim. Biophys.
Acla 1999, 1433, 281, herein incorporated by reference. In

K to T:300 K in 30 ps before the production MD simulation

for 500 ps. The full minimization and equilibration procedure
Was repeated for each mutant. The MD simulations Were

performed With a periodic boundary condition in the NPT
ensemble at T:300 K With Berendsen temperature coupling
and constant pressure (P:1 atm) With isotropic molecule
based scaling disclosed in Berendsen, H. C.; Postma, 1. P. M.;
van Gunsteren, W. F.; DiNola, A.; Haak, 1. R. J. Comp. Phys.

1984, 81, 3684, herein incorporated by reference. The
SHAKE algorithm of Ryckaert, 1. P.; Ciccotti, G.; Berendsen,
H. C. J. Comp. Phys. 1977, 23, 327 (herein incorporated by
reference) Was applied to ?x all covalent bonds containing a
hydrogen atom, a time step of 2 fs Was used, and the non-bond
pair list Was updated every 10 steps. The pressure Was

50

to treat long-range electrostatic interactions. A residue-based
cutoff of 10 A Was applied to the noncovalent interactions.

brief, to initiate reactions, 100 nCi of [3H]cocaine Was mixed
With 100 pl of culture medium. Reactions proceeded at 370 C.

for varying times. Reactions Were stopped by adding 300 pl of
0.02 M HCl, Which neutralized the liberated benzoic acid
While ensuring a positive charge on the residual cocaine.
[3H]benzoic acid Was extracted by 1 ml of toluene and mea
55

sured by scintillation counting. Finally, the measured time
dependent radiometric data Were ?tted to the kinetic equation
so that the catalytic ef?ciency (km/KM) Was determined.
Depicted in FIG. 1 are plots of some important distances in

the MD-simulated (—)-cocaine binding With A328W/Y332G
60

adjusted by isotropic position scaling. The particle mesh
EWald (PME) method of Essmann, U.; Perera, L.; BerkoWitz,
M. L.; Darden, T. A.; Lee, H., Pedersen; L. G. J. Chem. Phys.
1995, 98, 10089, herein incorporated by reference, Was used

used sensitive radiometric assays based on toluene extraction
of [3 H] cocaine labeled on its benzene ring Were used in accor

65

BChE versus the simulation time, along With root-mean
square deviation (RMSD) of the coordinates of backbone
atoms in the simulated structure from those in the X-ray
crystal structure. MD trajectories for other complexes Were
similar to these tWo in FIG. 1, although the simulated average
distances are different. Summarized in Table 2 are the average

values of some important geometric parameters in the simu

lated complexes.
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TABLE 2
Average values of the geometric parameters6
BChE-cocaine bindinga
wild-type
wild-type with (+)—cocaineb
A328W/Y332A
A328W/Y332G
A328W/Y332A/Y419S

<D1>non
5.60
7.64
7.11
7.06
5.18

<D1> <D2> <D3> <D4>
.27
.69
.87
.96
.84

.77
.88
.30
.28
.64

.71
.30
.14
.52
.56

.37
.83
.01
.42
.97

RMSDd

<T>

nonpre

re

67
61
51
60
64

1.14
1.15
1.58
1.20
2.66

.27
.13
1.65
.35
.62

3Refers to (—)—cocaine binding with wild-type human BChE or (—)—cocaine binding with a mutant
BChE, unless indicated otherwise.

bRefers to (+)—cocaine binding with wild-type human BChE.
c<D1>non and <D1> represent the average distances between the S198 O? atom and the carbonyl
carbon of the cocaine benZoyl ester in the simulated non-prereactive and prereactive BChE-co
caine complexes, respectively. <D2>, <D3>, <D4> refer to the average values of the simulated
distances from the carbonyl oxygen of the cocaine benZoyl ester to the NH hydrogen atoms of
G116, G117, and A199 residues, respectively. <T> is the average value ofthe dihedral angle
formed by the S198 O? atom and the plane ofthe carboxylate group ofthe cocaine benZoyl ester.
See Scheme 2.

dThe root-mean-square deviation (RMSD) of the coordinates of backbone atoms in the simulated
structure from those in the X-ray crystal structure of BChE. “nonpre” and “pre” refer to the non

prereactive and prereactive BChE-cocaine complexes, respectively.

(—)- and (+)-cocaine binding with wild-type BChE. FIG. 2

The MD simulations of the prereactive complexes reveal

shows the binding structures of the simulated non-prereactive

that wild-type BChE binding with (—)-cocaine is essentially

and prereactive complexes of wild-type BChE binding with

25

the two enantiomers of cocaine. In the non-prereactive com

the same as the binding with (+)-cocaine in the binding site,
except for the different positions of methyl ester group of the

plexes with (—)- and (+)-cocaine, the methyl ester group of

substrates. The simulated average distances between the car

cocaine is positioned at the top of the H438 backbone, while
the cocaine benZoyl ester moiety is quasi-parallel to the
C40? side chain of S198 with a dihedral angle T of —80 and

bonyl carbon of the benZoyl ester and S198 O? are 3.27 and
30

3.69 A for (—)-cocaine and (+)-cocaine, respectively. More
over, the (+)-cocaine is stabilized more effectively by the
formation of strong hydrogen bonds with the backbone NH of
residues G116, G117, and A199 as summarized above in

140°, respectively.

Table 2. The cocaine benZoyl ester moiety is positioned quasi
35

perpendicular to S198 C40? with a dihedral angle T of ~67°

and ~61° for (—)- and (+)-cocaine, respectively.

40

A comparison was made between the currently simulated
structures of the BChE-cocaine binding with those simulated
previously by using a homology model of BChE and it was
noted that two major differences between the two sets of

45

structures. By using the X-ray crystal structure in accordance
with Nicolet et al, the acyl loop is positioned on the top of the
cocaine benZoyl ester moiety of the cocaine, whereas the acyl
loop is far from the cocaine benZoyl ester moiety in the
structure simulated starting from the homology model of
Zhan et al. The RMSD of the coordinates of backbone atoms

in the previously simulated prereactive BChE-(—)-cocaine
50

replaced by the MD-simulated prereactive BChE-(—)-cocaine
complex starting from the X-ray crystal structure. Despite

Scheme 2. Hydrolysis of (—)-cocaine and (+)-cocaine.
Here, T refers to the dihedral angle formed by S198 O? and
the plane of carboxylate group of the cocaine benZoyl ester as
shown in the structure diagram below.
The simulated internuclear distances between the carbonyl
oxygen of cocaine benZoyl ester group and the NH hydrogen

complex from those in the X-ray crystal structure of BChE is
~2.0 A for the entire protein and ~3 .0 A for the acyl loop. The
RMSD value became ~2.4 A for the entire protein and ~3.3 A
for the acyl loop, when the X-ray crystal structure was

55

these structural differences, the benZoyl ester group of the
ligand is still close to the key residues (S197, G116, and
G1 17) in the BChE binding site. Some signi?cant differences
are associated with the distances between the S198 O? atom
and the carbonyl carbon of the cocaine benZoyl ester in non

5.18 A for (—)- and (+)-cocaine, respectively. Comparing the

prereactive complexes. The average values of this distance in
the non-prereactive complexes were ~9.5 and ~8.5 A for (—)
and (+)-cocaine, respectively, when a homology model was
used. Using the X-ray crystal structure to conduct the analy
sis, corresponding average values became ~5.6 and ~5.2 A,

simulated protein backbone structures to the X-ray crystal

respectively. Therefore, both (—)- and (+)-cocaine became

of G1 16, G117, and A199 are comparable for the two enan
tiomers. The simulated average distances between the carbo

nyl carbon of the benZoyl ester and S198 O? are 5.60 A and

60

structure of Nicolet et al, one can see from FIG. 1 that the 65 closer to the binding site when the homology model was

RMSD values are all smaller than 1.3 A for the whole protein

replaced by the X-ray crystal structure. However, no signi?

structures.

cant changes of the binding in the prereactive complexes were

US 7,438,904 B1
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observed When the used homology model Was replaced by the
X-ray crystal structure. The average values of the simulated
distance between the S198 O? atom and the carbonyl carbon
of the cocaine benZoyl ester in the prereactive complexes are
alWays close to ~3 .5 A for both (—)- and (+)-cocaine no matter
Whether the X-ray crystal structure or homology model of

rotation Was signi?cant only in A328W/Y332A BChE, thus
suggesting that the energy barrier for the (—)-cocaine rotation
in A328W/Y332G BChE should be slightly loWer than that in
A328W/Y332A BChE.

BChE Was used as the starting structure. The similar compu

directly contact With the cocaine molecule. The Y4 1 9S muta
tion Was tested because it Was initially expected that this
mutation Would further increase the free space of the active
site pocket so that the (—)-cocaine rotation could be easier.
HoWever, as seen in Table 2 above, the average distance

Concerning (—)-cocaine binding With A328W/Y332A/
Y419S BChE,Y419 stays deep inside the protein and does not

tational results obtained from the use of the X-ray crystal
structure and homology model of BChE provides evidence
that the fundamental structural and mechanistic insights
obtained from the previous computational studies of Zhan et
al are reliable, despites the previous simulations Were per

betWeen the carbonyl carbon of cocaine benZoyl ester and

formed by using the homology model When the X-ray crystal

S198 O? atom in the simulated prereactive complex Was as
long as 5.84 A. The average distances betWeen the carbonyl
oxygen of the cocaine benZoyl ester and the NH hydrolysis

structure Was not available.

Further, the simulated structures of the non-prereactive
BChE-cocaine complexes Were superimposed With the cor

atoms of G116, G117, and A199 residues are betWeen 4.56
and 6.97 A; no any hydrogen bond betWeen them. In addition

responding prereactive complexes. As shoWn in FIG. 3, the
20

to the internuclear distances, another interesting geometric
parameter is the dihedral angle, T, formed by S198 O? and the
plane of the carboxylate group of the cocaine benZoyl ester.

25

As seen in Table 2, the T values in the prereactive complexes
of cocaine With Wild-type BChE and all of the BChE mutants
other than A328W/Y332A/Y419S BChE all slightly deviate
from the ideal value of 900 for the nucleophilic attack of S 1 98
O? at the carbonyl carbon of cocaine. The T value in the

(—)-cocaine rotation in the BChE active site from the non

prereactive complex to the prereactive complex is hindered
by some residues as the positions ofY332, A328, and F329
residues in the non-prereactive complex are signi?cantly dif
ferent from the corresponding positions in the prereactive
complex, Whereas none of these residues hinders the (+)
cocaine rotation in the BChE active site from the non-prere

active complex to the prereactive complex because these resi
dues stay in nearly the same positions in the tWo BChE-(+)

prereactive complex of (—)-cocaine With A328W/Y332A/

cocaine complexes.

Y419S BChE is 164°, Which is considerably different from

(—)-cocaine binding With BChE mutants. NoW that the
(—)-cocaine rotation from the non-prereactive complex to the
prereactive complex has been knoWn to be the rate-determin
ing step of the BChE-catalyzed hydrolysis of (—)-cocaine as
shoWn by Zhan et al, useful BChE mutants should be
designed to speci?cally accelerate the change from the non

the ideal value of 90°.

Catalytic activity. The aforementioned discussion provides
30

non-prereactive complex to the prereactive complex, the rate
determining step for the BChE-catalyzed hydrolysis of (—)

prereactive BChE-(—)-cocaine complex to the prereactive
complex. The question is Whether MD simulation can be

evidence that the energy barriers for the (—)-cocaine rotation
in A328W/Y332A and A328W/Y332G BChE’s from the

35

performed to help design BChE mutants that have higher

cocaine, should be loWer than that in the Wild-type BChE.
Thus, the MD simulations predict that both A328W/Y332A
and A328W/Y332G BChE’s should have a higher catalytic

catalytic activity for (—)-cocaine hydrolysis.

activity than the Wild-type BChE for (—)-cocaine hydrolysis.

In the simulated non-prereactive complex, the average dis
tance betWeen the carbonyl carbon of cocaine benZoyl ester
and S198 O? is 7.6 A forA328W/Y332A BChE and 7.1 A for

Further, the MD simulations also suggest that the energy
barrier for the (—)-cocaine rotation in A328W/Y332G BChE
should be slightly loWer than that in A328W/Y332A BChE

40

and, therefore, the catalytic activity ofA328W/Y332G BChE
for the (—)-cocaine hydrolysis should be slightly higher than

A328W/Y332G BChE, as seen in Table 2 above. In the simu

lated prereactive complex, the average values of this impor

the activity of A328W/Y332A BChE. In addition, the MD
simulations predict that A328W/Y332A/Y419S BChE

tant internuclear distance become 3.87 and 3.96 A for

A328W/Y332A and A328W/Y332G BChE’s, respectively.
Compared to the simulated Wild-type BChE-(—)-cocaine pre
reactive complex, the average distances betWeen the carbonyl
carbon of the cocaine benZoyl ester and S198 O? in the pre
reactive complex of (—)-cocaine With A328W/Y332A and
A328W/Y332G BChE’s are all slightly longer, Whereas the
average distances betWeen the carbonyl oxygen of the
cocaine benZoyl ester and the NH of G1 16, G117, and A199
residues are all shorter. This provides evidence that (—)-co

45

sis because (—)-cocaine binds With the mutant BChE in a Way
that is not suitable for the catalysis.

The catalytic ef?ciency (km/KM) of A328W/Y332A
50

BChE for (—)-cocaine hydrolysis Was reported to be 8.56><106

M H11I1_l,Wh1Ch1S 9.39 times ofthe kcat/KMvalue (9.11><105

caine more strongly bind With A328W/Y332A and A328W/

Y332G BChE’s in the prereactive complexes. More impor
tantly, the (—)-cocaine rotation in the active site of A328W/

should have no catalytic activity, or have a considerably loWer

catalytic activity than the Wild-type, for (—)-cocaine hydroly

55

M minl) of the Wild-type BChE. To examine these theoretical
predictions of the relative activity for A328W/Y332G and
A328W/Y332A/Y419S BChE’s, aA328W/Y332A, A328W/
Y332G, and A328W/Y332A/Y419S BChE Was produced

through site-directed mutagenesis. To minimiZe the possible

Y332A and A328W/Y332G BChE’s from the non

prereactive complex to the prereactive complex did not cause

systematic experimental errors of the kinetic data, kinetic

considerable changes of the positions of A332 (or G332),

studies Were performed With all of three mutants under the

same condition and compared the catalytic ef?ciency of the

W328, and F329 residues as seen in FIG. 4, compared to the

(—)-cocaine rotation in the active site of Wild-type BChE.
These results provide evidence that A328W/Y332A and

60

A328W/Y332G and A328W/Y332A/Y419S to that of the

A328W/Y332A for (—)-cocaine hydrolysis at benZoyl ester

A328W/Y332G BChE’s should be associated With loWer

group. Based on the kinetic analysis of the measured time

energy barriers than the Wild-type for the (—)-cocaine rotation

dependent radiometric data, the ratio of the kcat/KM value of

from the non-prereactive complex to the prereactive complex.
Further, (—)-cocaine binding With A328W/Y332G BChE is
very similar to the binding With A328W/Y332A BChE, but

the position change of P329 residue caused by the (—)-cocaine

65

A328W/Y332G BChE to the kcat/KM value of A328W/
Y332A BChE for the (—)-cocaine hydrolysis Was determined
to be ~2.08, or A328W/Y332G BChE has a kcat/KM value of
~1.78><107 M min“ 1 for the (—) -cocaine hydrolysis. The radio
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metric data show no signi?cant catalytic activity forA328W/

A328W/Y332A BChE, thus suggesting that the energy bar
rier for (—)-cocaine rotation in A328W/Y332G BChE should
be slightly loWer than that in A328W/Y332A BChE. It has
also been demonstrated that (—)-cocaine binds With A328W/

Y332A/Y4l9S BChE. These experimental data are consis
tent With the theoretical predictions based on the MD
simulations.

Conclusion. Molecular modeling, molecular docking, and
molecular dynamics (MD) simulations Were performed to

Y332A/Y4l9S BChE in a Way that is not suitable for the

catalysis.

study cocaine binding With human butyrylcholinesterase

Based on the computational results, both A328W/Y332A

(BChE) and its mutants, based on a recently reported X-ray
crystal structure of human BChE. The MD simulations of

and A328W/Y332G BChE’s have catalytic activity for (—)
cocaine hydrolysis higher than that of Wild-type BChE and

Coca?“ blndlng with Wi1d"YP‘?BChE led ‘0 avferage BChE‘ 10 the activity of A328W/Y332G BChE should be slightly
coca1ne b1nd1ng~structures similar to those obtained recently
from the
slmulémops base‘? on a homology model of

higher than that OfA328W/Y332A BChE’ Whereas A328W/
Y332A/Y4l9S BChE is expected to lose the catalytic activ

B_ChE’ desplte the_ slgm?cam dlfference found at the acyl

ity. The computational predictions are completely consistent

bmdmgPoFlfet- _Th1s Con?rms the fundamental Structural and 15 With the experimental kinetic data, providing evidence that
mechamsnc lnslghts Obtamed from the pnor Computanonal
Studles of Zhan et a_1 based on a homology model of BChE’

the used computational protocol, including molecular mod
eling, molecular docking, and MD simulations, is reliable in

e'g"_the r2_lte'detenp1mng Step for BChE'Catab/Zeq hydra-‘X515

prediction of the catalytic activity of BChE mutants for (—)

of biologically active (—)-coca1ne is the (—)-coca1ne rotat1on
.

.

.

.

Cocaine hydrolysis‘
20

1n the BChE active site from the non-prereact1ve BChE-(—)

cocaine complex to the prereactive complex.

Experiment 2

The MD simulations further reveal that the (—)-cocaine
rotation in the active site of Wild-type BChE from the non-

MD Simulations and Quantum

prereactive complex to the prereactive complex is hindered 25

Mechanical/Molecular Mechanical (QM/MM)

by some residues such that the positions ofY332, A328, and

Calculations Relating to a l99S/A328W/Y332G

F329 residues in the non-prereactive complex are signi?cantly different from those in the prereactive complex. Com
pared to (—)-cocaine binding With Wild-type BChE, (—)-co-

Mutant (Mutant l) (SEQ ID NO: 1).

Generally speaking, for rational design of a mutant enZyme

caine more strongly bind With A328W/Y332A and A328W/ 30 Witha higher catalytic activity fora given substrate, one needs
Y332G BChE’s in the prereactive complexes. More
to design a mutation that can accelerate the rate-determining
importantly, the (—)-cocaine rotation in the active site of
step of the entire catalytic reaction process While the other
A328W/Y332A and A328W/Y332G BChE’s from the non-

steps are not sloWed doWn by the mutation. Reported com

prereactive complex to the prereactive complex did not cause 35 putational modeling and experimental data indicated that the
considerable changes of the positions of A332 or G332,
formation of the prereactive BChE-(—)-cocaine complex (ES)
W328, and F329residues.These results provide evidence that
is the rate-determining step of (—)-cocaine hydrolysis cata
A328W/Y332A and A328W/Y332G BChE’s are associated
lyZed by Wild-type BChE as disclosed by Sun et al, Zhan et al
With loWer energy barriers than Wild-type BChE for the (—)and HamZa, A.; Cho, H.; Tai, H.-H.; Zhan, C.-G. J. Phys.
cocaine rotation from the non-prereactive complex to the 40 Chem. B 2005, 109, 4776, herein incorporated by reference,

prereactive complex. Further, (—)-cocaine binding With

Whereas the rate-determining step of the corresponding (+)

A328W/Y332G BChE is very similar to the binding With
A328W/Y332A BChE, but the position change of P329 residue caused by the (—)-cocaine rotation Was signi?cant only in

cocaine hydrolysis is the chemical reaction process consist
ing of four individual reaction steps disclosed by Zhan et al
and shoWn in Scheme 3 and Scheme 4 beloW.
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Scheme 3. Schematic representation of BChE-catalyzed

Were performed to model the protein environmental effects

hydrolysis of (—)-cocaine. Only QM-treated high-layer part

on the stabiliZation of the transition-state structure for BChE

of the reaction system in the QM/MM calculations are draWn.
Notation [H] refers to a non-hydrogen atom in the MM
treated loW-layer part of the protein and the cut covalent bond
With this atom is saturated by a hydrogen atom. The dash lines
in the transition state structures represent the transition bonds.
This mechanistic understanding is consistent With the
experimental observation of Sun et al, that the catalytic rate

catalyZed hydrolysis of (—)-cocaine. The simulated and cal
culated results indicate that the transition-state structure can

be stabiliZed better by the protein environment in Al99S/
A328W/Y332G mutant of BChE than that in the Wild-type.
The computational modeling led to a prediction of the higher
catalytic ef?ciency for the Al99S/A328W/Y332G mutant

against (—)-cocaine. The prediction has been con?rmed by

constant of Wild-type BChE against (+)-cocaine is pH-depen

Wet experimental tests shoWing that the Al99S/A328W/
Y332G mutant has a signi?cantly improved catalytic e?i

dent, Whereas that of the same enZyme against (—)-cocaine is
independent of the pH. The pH-dependence of the rate con
stant for (+)-cocaine hydrolysis is clearly associated With the
protonation of H438 residue in the catalytic triad (S198,
H438, and E325). For the ?rst and third steps of the reaction
process, When H438 is protonated, the catalytic triad cannot
function and, therefore, the enZyme becomes inactive. The
loWer the pH of the reaction solution is, the higher the con
centration of the protonated H438 is, and the loWer the con
centration of the active enZyme is. Hence, the rate constant
Was found to decrease With decreasing the pH of the reaction

ciency against (—)-cocaine. All of the obtained results clearly
demonstrate that directly modeling the transition-state struc
ture provides a reliable computational approach to the ratio
nal design of a high-activity mutant of BChE against (—)
cocaine.
MD simulations. It should be stressed that a critical issue
exists With regard to any MD simulation on a transition state.

In principle, MD simulation using a classical force ?eld (mo
20

solution for the enZymatic hydrolysis of (+)-cocaine.
Based on the above mechanistic understanding, the efforts
for rational design of the BChE mutants reported in literature
have been focused on hoW to improve the ES formation

25

process. Indeed, several BChE mutants, including A328W,
A328W/Y332A, A328W/Y332G, and F227A/S287G/

alWays associated With a ?rst-order saddle point on the poten
tial energy surface. Hence, MD simulation using a classical
force ?eld cannot directly simulate a transition state Without
any restraint on the geometry of the transition state. Never
theless, if one can technically remove the freedom of imagi
nary vibration in the transition state structure, then the num

A328W/Y332M, have been found to have a signi?cantly

higher catalytic ef?ciency (km/KM) against (—)-cocaine;
these mutants of BChE have an approximate 9 to 34-fold

lecular mechanics) can only simulate a stable structure cor
responding to a local minimum on the potential energy sur
face, Whereas a transition state during a reaction process is

30

ber of vibrational freedoms (normal vibration modes) for a
nonlinear molecule Will decrease from 3N-6. The transition

improved catalytic ef?ciency against (—)-cocaine. Experi

state structure is associated With a local minimum on the

mental observation also indicated that the catalytic rate con
stant of A328W/Y332A BChE is pH-dependent for both (—)

potential energy surface Within a subspace of the reduced
vibrational freedoms, although it is associated With a ?rst
order saddle point on the potential energy surface With all of
the 3N-6 vibrational freedoms. Theoretically, the vibrational
freedom associated With the imaginary vibrational frequency

and (+)-cocaine. The pH-dependence reveals that for both

(—)- and (+)-cocaine, the rate-determining step of the
hydrolysis catalyZed by A328W/Y332A BChE should be

35

in the transition state structure can be removed by appropri

either the ?rst or the third step of the reaction process. Further,
if the third step Were rate determining, then the catalytic

ately freeZing the reaction coordinate. The reaction coordi
nate corresponding to the imaginary vibration of the transi

ef?ciency of the A328W/Y332A mutant against (—)-cocaine
should be as high as that of the same mutant against (+)

40

also been observed that the A328W/Y332A mutant only has

a ~9-fold improved catalytic ef?ciency against (—)-cocaine,
Whereas the A328W/Y332A mutation does not change the

tion state is generally characterized by a combination of some

key geometric parameters. These key geometric parameters

cocaine because the (—)- and (+)-cocaine hydrolyses share the
same third and fourth steps (see Scheme 3). HoWever, it has
45

are bond lengths of the forming and breaking covalent bonds
for BChE-catalyzed hydrolysis of cocaine, as seen in Scheme
3. Thus, one just needs to maintain the bond lengths of the
forming and breaking covalent bonds during the MD simula

high catalytic activity against (+)-cocaine. This analysis of

tion on a transition state. Technically, one can maintain the

the experimental and computational data available in litera
ture clearly shoWs that the rate-determining step of (—)-co
caine hydrolysis catalyZed by the A328W/Y332A mutant

bond lengths of the forming and breaking covalent bonds by
simply ?xing all atoms Within the reaction center, by using

should be the ?rst step of the chemical reaction process.

some constraints on the forming and breaking covalent
50

bonds, or by rede?ning the forming and breaking covalent

Further, recently reported computational modeling also sug

bonds. It should be pointed out that the only purpose of

gests that the formation of the prereactive BChE-(—)-cocaine
complex (ES) is hindered mainly by the bulky side chain of
Y332 residue in Wild-type BChE, but the hindering can be

performing such type of MD simulation on a transition state

removed by the Y332A orY332G mutation. Therefore, start
ing from the A328W/Y332A or A328W/Y332G mutant, the

is to examine the dynamic change of the protein environment
55

truly rational design of further mutation(s) to improve the
catalytic ef?ciency of BChE against (—)-cocaine should aim
to decrease the energy barrier for the ?rst reaction step With

out signi?cantly affecting the ES formation and other chemi
cal reaction steps.
The folloWing rational design of a high-activity mutant of
BChE against (—)-cocaine is based on detailed computational
modeling of the transition state for the rate-determining step
(i.e., the ?rst step of the chemical reaction process). Molecu

lar dynamics (MD) simulations and hybrid quantum
mechanical/molecular mechanical (QM/MM) calculations

surrounding the reaction center and the interaction betWeen
the reaction center and the protein environment. For this
study, of interest is the simulated structures, as the total ener
gies calculated in this Way are meaningless.
The initial BChE structures used in the MD simulations
Were prepared based on the previous MD simulation in accor

60

dance With HamZa et al on the prereactive ES complex for

Wild-type BChE With (—)-cocaine in Water by using Amber7
program package. The previous MD simulations on the pre

reactive BChE-(—)-cocaine complex (ES) started from the
65

X-ray crystal structure of Nicolet et al deposited in the Protein
Data Bank (pdb code: 1 POP). The present MD simulation on
the transition state for the ?rst step (TSl) Was performed in
such a Way that bond lengths of the partially formed and
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partially broken covalent bonds in the transition state Were all

residue-based cutoff of 10 A Was utilized to the non-covalent
interactions. The coordinates of the simulated systems Were

constrained to be the same as those obtained from our previ
ous ab initio reaction coordinate calculations on the model

collected every 1 ps during the production MD stages.
QM/MM calculations. For each TS1 structure examined,

reaction system of Wild-type BChE in accordance With Zhan
et al. The partially formed and partially broken covalent
bonds in the transition state Will be called “transition” bonds

after the MD simulation Was completed and a stable MD

beloW, for convenience. A suf?ciently long MD simulation

trajectory Was obtained, all of the collected snapshots of the
simulated structure, excluding those before the trajectory Was
stabilized, Were averaged and further energy-minimized. The
energy-minimized average structure (With the transition

With the transition bonds constrained should lead to a reason

able protein environment stabilizing the reaction center in the
transition-state structure simulated. Further, the simulated
TS1 structure for Wild-type BChE With (—)-cocaine Was used
to build the initial structures of TS1 for the examined BChE
mutants With (—)-cocaine; only the side chains of mutated
residues needed to be changed.

bonds constrained) Was used as an initial geometry to carry

out a further geometry optimization by using the ONIOM

approach of Dapprich, S.; Komaromi, 1.; Byun, K. S.; Moro
kuma, K.; Frisch, M. J. J Mol. Slrucl. (Theochem) 1999, 461,

The partial atomic charges for the non-standard residue
atoms, including cocaine atoms, in the TS1 structures Were

1-21, herein incorporated by reference, implemented in the

calculated by using the RESP protocol implemented in the
Antechamber module of the Amber7 package folloWing elec

Gaussian03 program of Frisch, M. J. et al Gaussian 03, Revi

trostatic potential (ESP) calculations at ab initio HF/6-31G*
level using Gaussian03 program knoWn in the art. The geom

porated by reference. TWo layers Were de?ned in the present
ONIOM calculation: the high layer, as depicted in Scheme 3
above, Was calculated quantum mechanically at the ab initio
HF/3-21G level, Whereas the loW layer Was calculated
molecular mechanically by using the Amber force ?eld as

sion A.1, Gaussian, Inc., Pittsburgh, Pa., 2003, herein incor
20

etries used in the ESP calculations came from those obtained

from the previous ab initio reaction coordinate calculations of
Zhan et al, but the functional groups representing the oxyan
ion hole Were removed. Thus, residues G116, G117, and
A199 Were the standard residues as supplied by Amber7 in the
MD simulations. The general procedure for carrying out the

25

MD simulations in Water is essentially the same as that used

in our previously reported other computational studies
including Zhan et al, Hamza et al and (a) Zhan, C.-G.; Norb
erto de Souza, 0.; Rittenhouse, R.; Omstein, R. L. J. Am.
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Chem. Soc. 1999, 121, 7279, (b) Koca, J.; Zhan, C.-G.; Rit
tenhouse, R.; Omstein, R. L. J. Am. Chem. Soc. 2001, 123,

817, (c) Koca, J .; Zhan, C.-G.; Rittenhouse, R. C.; Omstein,
R. L. J Compuz. Chem. 2003, 24, 368, (d) Hamza, A.; Cho,
H.; Tai, H.-H.; Zhan, C.-G. Bioorg. Med. Chem. 2005, 13,
4544, herein all incorporated by reference. Each aforemen
tioned starting TS1 structure Was neutralized by adding chlo
ride counterions and Was solvated in a rectangular box of
TIP3P Water molecules With a minimum solute-Wall distance
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(—)-cocaine, key functional groups from the catalytic triad
(S198, H438, and E325), and the three residues, i.e., G116,
45

G1 17, andA199 (or S199 for a particular mutant, see Scheme

4), of the possible oxyanion hole, Whereas the entire enzyme
structure of BChE Was included in the MM-treated loW layer.
A language computer program Was developed to automati
50

cally generate the input ?les for the ONIOM calculations
folloWing the MD simulations and subsequent energy mini
mizations in order to make sure that the atom types used for
all loW-layer atoms are the same as What Were used in the

Amber7. During the TS1 geometry optimization using the
55

tWo-layer ONIOM, the length of a key transition C40 bond
Was ?xed Which dominates the reaction coordinate; all of the
other transition bond lengths Were relaxed. The C and O
atoms in the key transition C40 bond are the carbonyl car

bon of (—)-cocaine benzoyl ester and the 0V atom of S198,
60

respectively, according to the previous reaction coordinate

65

calculations With an active site model of Wild-type BChE of
Zhan et al.
Most of the MD simulations and QM/MM calculations
Were performed in parallel on an HP supercomputer (Super

covalent bonds containing hydrogen atoms. The non-bonded
pair list Was updated every 10 steps. The particle mesh EWald

(PME) method in accordance With Essmann, U.; Perera, L.;
BerkoWitz, M. L.; Darden, T. A.; Lee, H., Pedersen, L. G. J.

tions, the same part of the enzyme Was included in the QM

treated high layer. So, the QM-treated high layer included

coupling and P:1 atm With isotropic molecule-based scaling
Were applied. The SHAKE algorithm Was used to ?x all

optimization of this enzymatic reaction system shoWn by

As depicted in Scheme 3, for all of these QM/MM calcula
40

(—)-cocaine is only 8417 (for the Wild-type BChE). All of the

gradually heated from T:10 K to T:298. 15 K in 30 ps before
running the MD simulation at T:298.15 K for 1 ns or longer,
making sure that a stable MD trajectory Was obtained for each
of the simulated TS1 structures. The time step used for the
MD simulations Was 2 fs. Periodic boundary conditions in the
NPT ensemble at T:298.15 K With Berendsen temperature

culations With an active site model of Wild-type BChE dem
onstrate that the HF/ 3 -21G level is adequate for the geometry

Zhan et al, although the ?nal energy calculations for calcu

Madura, J.; Klein, M. L.J. Chem. Phys. 1983, 79, 926, herein

MD simulations Were performed by using the Sander module
of Amber7 package. The solvated systems Were carefully
equilibrated and fully energy minimized. These systems Were

tions of Vreven, T.; Morokuma, K.J. Chem. Phys. 2000, 113,
2969-2975 and Frisch, M.; Vreven, T.; Schlegel, H. B.; Moro
kuma, K. J. Compul. Chem. 2003, 24, 760-769, herein both
incorporated by reference. Previous reaction coordinate cal

lating the energy barriers must be carried out at a higher level.
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